Artiglass NRFitTM Tip L.O.R. Glass Syringes

FDA 510(k) K213800 · Artiglass Srl

Substantially Equivalent

510(k) numberK213800

Submission

Device name
Artiglass NRFitTM Tip L.O.R. Glass Syringes
Applicant
Artiglass Srl
Due Carrare, IT
Received
December 6, 2021
Decision date
May 19, 2022
Decision
Substantially Equivalent (SESE)
Type
Special 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
QEH – Piston Syringe With Neuraxial Connector – Epidural, Peripheral, And/Or Indirect Cerebral Spinal Fluid Contact
Device class
Class II (moderate risk)
Regulation
21 CFR 880.5860
Specialty
General Hospital

A neuraxial piston syringe is intended to inject or withdraw fluid from the neuraxial space with neuraxial specific connections. This product code may include epidural, peripheral, subarachnoid/spinal block, intrathecal and/or intracerebroventricular administration routes. The connector for neuraxial applications is intended to facilitate ANSI/AAMI/ISO 80369-6:2016 compliant neuraxial specific…

Other 510(k)s with product code QEH

510(k)DeviceApplicantDecision
K241385Omnifix Syringe NRFitQEH · Traditional B.Braun Medical, Inc.07/13/2024SE
K201031NRFit® Caps, Male and Female Neuraxial Tip CapsQEH · Traditional International Medical Industries, Inc.12/16/2020SE
K192538BD Syringe NRFit Lok and BD Syringe NRFit SlipQEH · Traditional Becton, Dickinson and Company09/04/2020SE
K181374NRFit SyringeQEH · Traditional Jiangsu Caina Medical Co.,Ltd12/14/2018SE

More from Jiangsu Caina Medical Co.,Ltd

510(k)DeviceDecision
K122416Artiglass L. O.R. Glass SyringeFMF · Traditional 05/03/2013SE

Questions and answers

When was Artiglass NRFitTM Tip L.O.R. Glass Syringes cleared by the FDA?

Artiglass NRFitTM Tip L.O.R. Glass Syringes (K213800) received a 510(k) decision of Substantially Equivalent on May 19, 2022, 164 days after the submission was received.

What is the product code of K213800?

The FDA product code is QEH – Piston Syringe With Neuraxial Connector – Epidural, Peripheral, And/Or Indirect Cerebral Spinal Fluid Contact , a Class II (moderate risk) device regulated under 21 CFR 880.5860.